Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.
Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.
复制标题
DOI:
10.1002/cmdc.200800292
复制
发表时间:
2009-03
期刊:
影响因子:
3.4
通讯作者:
Bulaj, Grzegorz
中科院分区:
文献类型:
--
作者:
Han, Tiffany S.;Zhang, Min-Min;Walewska, Aleksandra;Gruszczynski, Pawel;Robertson, Charles R.;Cheatham, Thomas E., III;Yoshikami, Doju;Olivera, Baldomero M.;Bulaj, Grzegorz
Disulfide bridges, which stabilize the native conformation of conotoxins impose a challenge in the synthesis of smaller analogs. In this work, we describe the synthesis of a minimized analog of the analgesic μ-conotoxin KIIIA that blocks two sodium channel subtypes, the neuronal NaV1.2 and skeletal muscle NaV1.4. Three disulfide-deficient analogs of KIIIA were initially synthesized in which the native disulfide bridge formed between either C1-C9, C2-C15 or C4-C16 was removed. Deletion of the first bridge only slightly affected the peptide’s bioactivity. To further minimize this analog, the N-terminal residue was removed and two non-essential Ser residues were replaced by a single 5-amino-3-oxapentanoic acid residue. The resulting “polytide” analog retained the ability to block sodium channels and to produce analgesia. Until now, the peptidomimetic approach applied to conotoxins has progressed only modestly at best; thus, the disulfide-deficient analogs containing backbone spacers provide an alternative advance toward the development of conopeptide-based therapeutics.
登录
查看更多内容
影响因子:
3.6
作者:
Lewis, Richard J.;Schroeder, Christina I.;Alewood, Paul F.
通讯作者:
Alewood, Paul F.
影响因子:
2.9
作者:
CHEN, YH;YANG, JT;CHAU, KH
通讯作者:
CHAU, KH
影响因子:
3.5
作者:
Baell, JB;Duggan, PJ;Schroeder, CI
通讯作者:
Schroeder, CI
影响因子:
7.3
作者:
Jin, Ai-Hua;Daly, Norelle L.;Alewood, Paul F.
通讯作者:
Alewood, Paul F.
影响因子:
--
作者:
Green, Brad R.;Catlin, Philip;Bulaj, Grzegorz
通讯作者:
Bulaj, Grzegorz